If you haven’t read the first two posts in the series, you’ll appreciate this more if you read them first. Find them here at: www.ekalore.com/ars
In our last post described the mergers and acquisitions that lead to FujiFilm owning DioSynth Biotechnologies. The business continues to thrive and grow.
The CEO has recently stated:
“We're a joint venture in Fujifilm and Mitsubishi. We don't publicize too much the Mitsubishi piece. It's an 80/20 [split] but Mitsubishi are long-term trading partners of the world and so we use that expertise in terms of partnership, and we use the Fuji expertise in manufacture and technology development. That's where we come from.”
Ingredients for an Alien Invader
:
1) Expertise and know-how purchased from first class enterprises that are also partners (Merck, Mitsubishi)
2) Capital from a totally different market (imaging)
3) Technology advantages in manufacturing and process
Fuji continues to invest in DioSynth even as sales and market presence grow. Capital plant investments at DioSynth total more than $3.5B, including major investments in their North Carolina and UK Plants.
The Alien Invader has already landed.
If you’d like to comment, differ with our conclusions, or set up a time with an analyst to talk through your own situation – reach out to us at www.ekalore.com/contact
コメント